Dexter Susan 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Dexter Susan
Chief Technical Officer
Transactions
- Purchase
Common Stock
2023-06-14$0.70/sh+10,000$7,000→ 33,667 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6972 to $0.6999 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- [F2]Includes unvested restricted stock awards.